New insulin platform aims to help diabetes patients stay on track

NCT ID NCT05893797

First seen Nov 11, 2025 · Last updated Apr 25, 2026 · Updated 18 times

Summary

This study tested a connected insulin management platform to see if it helps people with type 1 or type 2 diabetes take their insulin doses on time and keep their blood sugar in a healthy range. About 36 participants used the platform along with continuous glucose monitoring. The goal was to reduce missed insulin doses and improve glucose control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU - l'Assistance Publique - Hôpitaux de Marseille

    Marseille, 13005, France

  • CHU Strasbourg-Hautepierre

    Strasbourg, Alsace, 67098, France

  • CHU de Besancon Hopital Jean Minjoz

    Besançon, 25030, France

  • CHU de Caen Hôpital Cote de Nacre

    Caen, Cedex 9, 14033, France

  • CHU de Lyon

    Lyon, 69008, France

  • Centre Hospitalier Sud Francilien-Pharmacie

    Corbeil-Essonnes, 91100, France

  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet

    Nice, 6202, France

  • Chu de Grenoble

    Grenoble Cédex 9, 38043, France

  • Groupe Hospitalier Mutualiste Les Portes du Sud

    Vénissieux, 69200, France

Conditions

Explore the condition pages connected to this study.